Adjuvant chemotherapy for breast cancer: association of obesity with toxicity
Dr. Kirsten Nyrop
It is not known whether high body mass index (BMI) is a risk factor for higher toxicity from chemotherapy for cancer. A cross-sectional study at the University of North Carolina at Chapel Hill investigated the association of obesity with toxicity of adjuvant chemotherapy for early-stage breast cancer. Patients with obesity reported higher chemotherapy toxicity as compared to patients without obesity; however, this did not result in differences in treatment completion.
